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ABSTRACT
Effects of Resveratrol Supplementation on Glycemic Response and Oxidant Status
in Moderately Exercised Mature Quarter Horse Geldings
Jennie L. Zambito
Resveratrol, a naturally occurring phytocompound is known to exert numerous
health benefits including improved insulin sensitivity and glucose tolerance, along with
decreased tissue damage due to reactive oxygen species (ROS). This compound is
incorporated in a multitude of supplements targeted to performance horses, yet no
research in an athletic equine model has been completed to date. Therefore, this study
was performed to test the hypothesis that resveratrol supplementation would improve
glucose tolerance and insulin sensitivity, while reducing oxidant damage in an exercising
model. Six, healthy, fit aged (10.5+1.5yr, ~500kg) Quarter Horse geldings were assigned
to three treatment groups in a Latin Square random crossover design with one week
between crossovers. Horses either received no supplementation (control, C) or one of two
treatments (T); low dose (L, 2.5g of trans-resveratrol) and high dose (H, 5g of transresveratrol) administered on a daily basis for 14 days. Body weights (BW), blood
samples, and muscle biopsies were collected on day 0 and day 14 of each
supplementation period. All horses were moderately exercised 3 times a week for 60
minutes with an average heart rate of 90 bpm. A frequently sampled intravenous glucose
tolerance test (FSIGT) was conducted on day 10 of supplementation during each
treatment period. Feed intake data was collected daily. Samples from day 0 and 14 were
analyzed for thiobarbituric acid reactive substances (TBARS), while FSIGT samples
were analyzed for plasma insulin and glucose. The null hypothesis was rejected when
P<0.05, and trends were identified when P < 0.10. Minimal model analysis of FSIGT,
along with evaluation of baseline inulin and glucose concentrations, and area under the
glucose and insulin curve showed no effect of resveratrol supplementation (P > 0.05).
Plasma TBARS was unaffected by resveratrol supplementation (P > 0.05) within this
model. Body weight did not change due to T, yet contrast between C and T displayed
trends toward increased feed intake as % BW of both hay and concentrate (P < 0.10). In
conclusion, resveratrol supplementation in the moderately exercised horse does not
improve insulin sensitivity or glucose tolerance, or overall lipid peroxidation. Increased
feed intake displayed by T over C may have a potential application for a high
performance animal. These observations display a need to further evaluate the effects of
resveratrol in other equine models, and a more in depth assessment of resveratrol within
the athletic horse.
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INTRODUCTION
The horse is an extraordinary athlete subjected to numerous stressors during the
course of exercise, including oxidative stress and inflammation. During exercise,
oxidation of energy substrates is critical to provide the working muscles with enough fuel
to complete the desired task. As the rate of oxidation increases, the production of
reactive oxygen species, specifically free radicals, also increases. Damage to vital tissues
are caused by free radicals, by destroying cell proteins, fatty acids and DNA1 which can
result in lameness and an inability to perform due to muscle soreness in horses.
Antioxidants naturally occurring within the body or supplemented in the diet aid in
protecting the tissues from the damaging effects of free radicals by inhibiting production
or up-regulating degradation of free radicals as well as by promoting repair of damaged
cells or tissues. 2
At the same time, metabolic syndrome and insulin resistance have been well
characterized in both performance and non-athletic horses. Insulin resistance has been
implicated in the development of debilitating disorders including laminitis and
osteochondritis3 and is linked to the upregulation of inflammatory pathways.
Both nutritional and exercise interventions are being researched for their ability to
lower insulin resistance while acting as an antioxidant. Resveratrol (trans-3, 4’, 5trihydroxystilbene), a phytocompound present in grapes, red wine, yucca, and peanuts,4-6
has been found to act as a powerful antioxidant and anti-inflammatory agent, along with
beneficial effects against ageing and metabolic diseases.7 The anti-inflammatory and
antioxidant characteristics of resveratrol have been studied within rodent and human
1

models;4-6,8,9 however, research in an equine model is severely lacking. Many nutritional
supplements fed to performance horses today contain resveratrol, yet information on the
efficacy of the compound to impact the glycemic response, inhibit the effects of free
radicals, and reduce inflammation is unknown. A better understanding of how resveratrol
contributes to equine health and potential performance could be obtained by evaluating
various parameters relating to glycemic response and levels of oxidative damage. This
data can then be utilized as preliminary evidence to support the use of resveratrol
supplementation in performance horses or in horses suffering from equine metabolic
syndrome or insulin resistance.
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CHAPTER I: LITERATURE REVIEW
The Athletic Horse
The horse is an extraordinary athlete, due to a compilation of physiologic
adaptations utilized to increase performance. From a survival standpoint, enhanced speed
was necessary to escape predators, and increased endurance was required to travel long
distances to find food or water. Through the domestication of horses, humans were able
to utilize this athleticism for work, travel and leisure. The various breeds are utilized for
the areas in which they excel, yet all horses display an ability to run and jump at a much
higher level than other animals of similar body size. This enhanced athletic ability of the
horse is due to high maximal aerobic capacity, large intramuscular energy stores, high
mitochondrial concentration in the muscle, efficiency of gait, and efficient
thermoregulation.10 All play an integral role in the superior athletic ability displayed by
the horse, yet for the purpose of this review, only factors influencing aerobic capacity and
metabolism will be discussed in detail.
Aerobic Capacity
Aerobic capacity encompasses oxygen transport, and movement of oxygenated
blood to the peripheral tissues for use, and the utilization of oxygen at the muscle. The
large aerobic capacity in the horse is primarily due to large maximum cardiac output and
higher hemoglobin concentration.10 Cardiac output is defined as the product of heart rate
and stroke volume, and is responsible for the amount of blood delivered to the tissues. At
times of increased oxygen needs, heart rate and stroke volume can increase to partially
compensate for the deficit, but other mechanisms must be recruited to match the body’s
needs.
3

Oxygen transport depends on the ability to move oxygen from the air to the
peripheral tissues efficiently. The circulation is responsible for moving oxygenated blood
from the lungs to the tissues for delivery at a level contingent upon the oxygen carrying
capacity of the blood. During exercise, when the need for oxygen in the working muscles
is elevated, the horse increases the amount of circulating red blood cells via splenic
contraction without a simultaneous increase in plasma volume.11 This increase in red
blood cells, and thereby hemoglobin, increases the oxygen carrying capacity of arterial
blood by up to 50% during intense exercise.3 By increasing the amount of oxygen carried
within the blood, greater amounts of oxygen can be unloaded at the tissues and utilized.
Oxygen utilization is achieved during aerobic respiration within the mitochondria.
Facilitation of increased oxygen delivery to the muscle is achieved by high capillary and
mitochondrial density, which maximize the effects of increased cardiac output and
splenic contraction.12 Mitochondria are responsible for providing energy to the working
muscle cell, and therefore the greater quantity of mitochondria within the muscle, the
greater the oxidative ability of the tissue. When provided with adequate substrate and
optimal oxygen delivery, aerobic capacity of the horse is far superior to other animals of
similar size and stature.10
Energy Storage
Oxidation of carbohydrates and fats provides the main source of chemical energy
for both resting and working cells. Glucose, an absorbable unit of simple carbohydrate
metabolism is stored as glycogen within the liver and muscle, with over 90% of total
body carbohydrate stored within the muscle in horses.7 Movement of glucose from the
circulation into the cell via insulin signaling is needed to facilitate synthesis of glycogen
4

and storage for later oxidation into ATP. High intramuscular concentration of energy
substrates are important for fueling muscle during exercise, as the movement of glucose
from blood into the muscle and consequently into the mitochondria is only slightly
(<10%) responsible for the energy utilized during intense exercise.13 Glucose
metabolism within the muscle differs between fiber types and work load, therefore the
entry of glucose into the cell is crucial for all types of exercise.

Equine Glucose Metabolism
The horse utilizes a range of hydrolyzable and fermentable forage carbohydrates
as its main source of energy. Pasture is the most common form of habitat and nutrition
for the horse, however in areas where pasture cannot meet the horse’s nutrient needs such
as during times of extreme weather, hay, or preserved pasture is often used. Forage must
be fed at a minimum of 1% of the horse’s body weight per day, and often can be fed at an
amount to meet the horse’s maintenance energy requirements.14 Approximately 75% of
plant matter is carbohydrate, which can be divided into two main categories: nonstructural carbohydrates (NSC), and structural carbohydrates.14 It is important to consider
the seasonal variation of carbohydrate content in pasture when feeding, as
supplementation or dietary restriction may be necessary for proper maintenance. As
forages mature from leafy to stemmy stages, the proportion of non-structural
carbohydrates (such as disaccharides, some oligosaccharides and starch equivalents, like
fructans) to structural carbohydrates (such as hemicellulose and cellulose) is reduced.15
Eating large amounts of feedstuffs high in NSCs may cause spillover of non-structural
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carbohydrates into the hind gut, where microbial fermentation of these nutrients can be
detrimental to the horse.
Digestion and Absorption
Digestion and absorption of the non-structural carbohydrates should occur in the
small intestine. Numerous factors can affect prececal digestibility, such as source,
processing and amount of starch present, timing of forage feeding, and individual
differences between horses.14 Initially, gastric acid in the stomach begins carbohydrate
hydrolysis independent of enzyme activity. Digesta then moves to the small intestine,
where further digestion is achieved via pancreatic -amylase, and amylopectinase cleave
-1,4 and -1,6 linkages of amylose and amylopectin respectively, producing
disaccharides and oligosaccharides.15 These products are then subjected to
disaccharidases sucrase, lactase and maltase in the brush border, which result in the
liberation of glucose, fructose and galactose for absorption.16 Glucose absorption occurs
along the brush border via the Na+/glucose cotransporter type 1 (SGLT1) moving
glucose into the enterocyte, and facilitative glucose transporters (GLUT) which transport
glucose through the basement membrane and into the circulation.17,18 For the purpose of
this review, the effects of glucose in the central circulation and uptake into the tissues
will be discussed later in detail due to the effects of glucose concentration on insulin
release. Fructose and galactose do not play an integral role in this response, and therefore
will not be discussed, although it is important to recognize their presence and need in
metabolic homeostasis.

6

Glycogen Storage and Usage
Upon entry into the liver or muscle, glucose can either be stored as glycogen, or
oxidized as a source of energy for immediate use. Entry into either pathway requires
glucose to first be phosphorylated into glucose-6-phosphate (G6P) by hexokinase or
glucokinase in the muscle and liver, respectively. If the body is in a fed state, where
energy substrates are high, G6P will enter the glycogen synthesis pathway. Main chain 1,4 linkages between glucose residues are formed via glycogen synthase, and the -1,6
branch points are formed by glycogen branching enzyme.19 The branched structure of
glycogen allows for increased solubility and to increase the number of reducing ends that
are able to react with glycogen synthase and phosphorylase.
Glucose molecules will continue to be added to glycogen in the postprandial state
until glucose and insulin concentrations begin to fall. At this time, glucagon is released,
and glucose can be liberated from glycogen in both the muscle and the liver via the action
of glycogen phosphorylase and glycogen debranching enzyme.19 Although the general
concept is the same, the removal of glucose from storage has differing purposes across
the tissues. Liver glycogen stores are used to maintain blood glucose; therefore, when
glucose levels drop, G6P is dephosphorylated by glucose-6-phosphatase, and enters the
bloodstream.19 Muscle lacks this enzyme, and glucose freed from glycogen will remain in
the muscle cell, and must be used for intracellular energy.

Glucose Homeostasis
Hormonal regulation is central to maintaining blood glucose concentrations at a
relatively constant level. A balance between insulin, glucagon and other hormones are
7

necessary to metabolic homeostasis. Normal equine blood glucose concentration should
be within the range of 40-70mg/dL,20 and an inability to maintain this basal level could
result in a multitude of detrimental changes to overall homeostasis within the body. For
example, prolonged elevation of glucose concentrations has a toxic effect on cells,21
whereas low concentrations can produce seizures and disorientation.22
The effects of these hormones reach far beyond their role in glucose metabolism,
and many intermediates within these pathways feed into other catabolic and anabolic
states. A prolonged period of fed or fasting metabolism can cause obesity, and insulin
resistance, or starvation, respectively. Achievement of optimal body condition,
performance and physiologic mechanisms is possible with proper management and
understanding of the detailed hormone functions within these systems.
Glycemic Response
The ability for a feedstuff to be hydrolyzed, absorbed and released into circulation
to elevate blood glucose concentration is generally regarded as the glycemic index of a
feed.15 The time needed for these steps to occur is different among various feeds, and can
be affected by processing methods, which impact the ability for digestive carbolytic
enzymes to contact the various polysaccharides within the feed.15 A feedstuff with a
lower glycemic index will release glucose slowly into the bloodstream over time,
whereas a high glycemic index feed will release glucose rapidly, causing blood glucose
concentrations to spike. Any increase in blood glucose concentration above baseline
concentrations will elicit an insulin release from the pancreas, which is aimed to decrease
glucose concentrations back to baseline; however, repeated, rapid peaks in glucose and
insulin can pose health concerns.15,16
8

Upon elevation of blood glucose concentration, glucose is transported into the
pancreatic  cell via facilitated diffusion by an insulin independent transporter, GLUT 2.
The degree to which blood glucose concentration is elevated will be proportionally
displayed within the pancreatic  cell, and thus will elicit an appropriately large
response.23 Simply stated, membrane depolarization occurs in response to glucose entry,
leading to intracellular calcium release, signaling the release of insulin-containing
secretory vesicles via exocytosis.23 Insulin is then able to reach its target tissues via
circulation, and elicit glucose uptake into the muscle and adipose tissues to reduce blood
glucose concentrations.
Glucose Transport
Glucose transport is the rate limiting step of glucose metabolism at the skeletal
muscle level.22 When insulin reaches the muscle, the hormone binds to the insulin
receptor, composed of two  and two  subunits, attached by a disulfide linkage,
resulting in insulin receptor substrate tyrosine kinase activity.24 The insulin receptor
phosphorylates several intracellular targets which serve as docking sites; the insulin
receptor substrate family (IRS). These proteins act as a docking site for
phosphatidylinositol-3 kinase (PI3K), and upon activation, PI3K functions to convert
phosphatidylinositol-2-phopshate (PIP2) to phosphatidylinositol-3-phosphate (PIP3).25
Then, PIP3 activates protein kinase B, which functions to recruit vesicles containing
GLUT 4 to the plasma membrane.25 Facilitated diffusion of glucose can then occur into
the cell, and in turn will aid in the decrease of blood glucose concentration. The GLUT 4
isoform is considered to be an insulin dependent transporter,26 due to its reliance on
hormone signaling to move the transporter to the membrane. The ability for insulin to
9

elicit this response within the cell is dependent on the receptor’s sensitivity to insulin,
along with the effectiveness of promoting the GLUT 4 translocation to the cell surface.

Insulin Sensitivity and Effectiveness
Proper insulinemic response requires both sensitivity of the insulin receptor, and
movement of GLUT4 to the membrane to facilitate glucose movement into the cell.
Impairments to either portion of this pathway can cause prolonged, increased levels of
circulating glucose, leading to an array of health concerns including insulin resistance.27
Determining an animal’s ability to dispose of glucose at a normal rate is dependent on
pancreatic responsiveness and insulin sensitivity.28 Understanding the mechanics behind
glucose tolerance can allow for determination of various supplements, exercise training
and disease effects on the individual parameters involved in this response.
Pancreatic responsivity is defined as the ability of pancreatic β-cells to secrete
insulin in response to glucose stimuli.28 Inability of glucose to elicit an insulin response
with enough amplitude to return glucose back to baseline levels can be viewed as
impairment in this signaling pathway. It is important, however, to note that diminution of
the insulin response may be due to rapid insulin degradation or neutralization by
antibodies before the hormone can make contact with its receptor and not due to
pancreatic responsiveness to stimuli.29
Insulin sensitivity is determined by the effect of insulin at the cellular level.
Interaction of the hormone with its receptor elicits the aforementioned cascade utilized to
bring glucose into the muscle and adipose tissue. Inability of insulin to elicit this response
may be caused by unresponsiveness of the receptor or an inability to properly translocate
10

sufficient GLUT4 to the membrane surface, and subsequent decrease in intracellular
glucose use.27,29 Whole body glucose tolerance is affected by the amount of insulin
secreted by the pancreas in response to glucose and sensitivity of the skeletal muscle to
insulin; therefore, both parameters need to be assessed together to gain a full
understanding of glucose homeostasis.
Measuring Insulin Sensitivity in Horses
Development of an accurate means of measuring and evaluating the relationship
between glucose and insulin has progressed from a simplistic approach to a
comprehensive picture. Initially, single, fasting glucose and insulin measurements were
used to identify any imbalance in these systems.29 Accuracy of this method was
questioned due to individual variation of these concentrations in a short period as a result
of stress, feeding or diurnal variation.29,30 Ratios of basal glucose-to-insulin have also
been utilized, where glucose-to-insulin ratios describe insulin sensitivity, and insulin-toglucose ratios describe pancreatic responsiveness to blood glucose.30 Tolerance testing is
also implemented to gain an integrated understanding of in vivo response to bolus
glucose doses, exogenous insulin injection, and the combined effect of both on glucose
homeostasis.
Oral glucose tolerance tests (OTT) are best utilized to assess small intestinal
absorption of glucose, resulting in hepatic glucose uptake and the endogenous release of
insulin into the body. Utilization of this test should be implemented to address issues of
malabsorption in the small intestine, and to a limited extent, endocrine function of the
pancreas and target tissue insulin resistance.31-34 In brief, the test is conducted after an
overnight fast, and a dose of 1g/kg BW glucose is administered via nasogastric tube.
11

Blood samples are then taken at various timepoints between 0 and 360 min, with peak
glucose concentration occurring between 90 and 120 min post dosage, and baseline
concentrations re-established after 4 to 6 h.31, 35, 36 Decreased response to glucose in
comparison to normal values may suggest reduced pancreatic function;36 however, it is
important to consider possible shortcomings of this procedure. Stress of nasogastric
intubation, delayed gastric emptying, variation in glucose administration rate, and
reduced intestinal absorption may also impact the validity of the test results.29, 36
Intravenous glucose tolerance testing has been widely used to evaluate the
differences between diet, breed and disease states of various equids.37-39 The variable
effect of glucose absorption by the digestive tract as seen in the OTT is eliminated in the
intravenous glucose tolerance test (IVGT).29 The test is conducted by infusing 0.5g
glucose/kg BW directly into the bloodstream of a fasted animal over a short period of
time, and collecting blood samples at various timepoints over 5 to 6 h post bolus glucose
administration. Glucose utilization and thereby insulin sensitivity can be calculated
relative to glucose half-life and fractional turnover rate.35 Normal horses should display
peak glucose concentrations around 15 min after infusion,30 and return to baseline
approximately one hour after the start of the test.22 Insulin response should parallel
glucose response curves, where peak insulin concentration should be seen 30 min post
glucose dose.36 Horses displaying a higher peak glucose concentration, delayed return to
baseline glucose concentration may be due to impaired insulin release or inhibited
glucose disposal.30 Unfortunately, with this test, it is only possible to determine if
impaired pancreatic -cell function is occurring by evaluation of serum insulin
concentrations. Evaluation of tissue level sensitivity must be evaluated by other means.
12

Insulin tolerance tests (ITT) are utilized to assess tissue sensitivity to insulin and
evaluate the animal’s response to hypoglycemia induced by the exogenous insulin dose.22,
30

Dosages range between 0.2 to 0.6 IU/kg BW, causing an approximate 50% drop in

blood glucose from starting values within 20 to 30 min post dose, and a return to fasting
values within 2 h. 35,

40

If any impairment is present within the test animal, glucose

concentrations will not fall as dramatically, and return to fasting glucose level will be
achieved at a faster rate. 20,31 Results of this test are not a comprehensive representation
of glucose homeostasis as it only address insulin function at the tissue level, and ability
for the body to recover from hypoglycemia induced by a bolus insulin dose.
In all of the above methods, endogenous insulin can fluctuate freely, and thus may
have an impact on glucose homeostasis during the test. A clamp technique was developed
in 1966 allowing for plasma glucose to be manipulated to a desired concentration,
thereby interrupting the negative feedback cycle through which glucose-insulin signaling
occurs.44 Although this places the animal in a non-physiologic environment, it currently
remains the most accurate tool used to determine the effects of hyperglycemia and
hyperinsulinemia on various tissues and pathways affected by these states. 22, 29, 27, 30, 36, 41,
42

The hyperglycemic clamp causes an acutely elevated glucose concentration held

constant at a predetermined level to suppress hepatic gluconeogenesis for the duration of
the test. Glucose infusion rate is therefore a measure of insulin secretion and therefore
can be utilized to quantify  cell sensitivity to glucose.22, 31 The hyperinsulinemic
euglycemic clamp supplies steady state insulin concentration during which the rate of
glucose infusion needed to maintain euglycemia displays insulin effectiveness at the
target tissues. Both types of clamp provide a unique set of information to aid in the
13

understanding of cellular glucose dynamics, yet a model to encompass physiologic
responses to glucose tolerance is also useful.
Frequently sampled intravenous glucose tolerance tests (FSIGT) combines the
theories described in the intravenous glucose and insulin tolerance tests by evaluating
pancreatic insulin secretion and tissue sensitivity in a physiologically relevant situation.
Procedure for this test involves rapid intravenous infusion of a bolus glucose dose at
0.33g/kg BW,43 followed by an exogenous intravenous insulin dose at 30mIU/kg of BW
20 min post glucose dose.20 The goal of this insulin infusion is to elicit a physiological,
not pharmacological insulin effect, without inducing hypoglycemia.20, 44 Simulation of
plasma glucose changes when insulin effects are applied can then be utilized to determine
insulin sensitivity.45 Frequent blood samples are taken after each respective dose, and
analyzed for glucose and insulin concentrations for later analysis through the Minimal
Model program (MinMod Millennium).
The Minimal Model program is designed to calculate variables used to describe
factors mediating glucose homeostasis. This analytical model has been validated within
the horse to evaluate normal versus disease states, 28, 43-46 and can be utilized to
differentiate between insulin resistance with or without pancreatic compensation.29
Interpretation of glucose and insulin dynamics can be accomplished with the use of two
mathematical models 47 representative of the effect of insulin to increase glucose uptake
and the effect of glucose to enhance insulin secretion.28 The insulin kinetics model breaks
down insulin responsiveness to glucose, 48 while the glucose kinetics model utilizes the
insulin time course response to predict glucose kinetics, thus resulting in a measure of
insulin sensitivity .47 Parameters of the minimal model of glucose and insulin dynamics
14

consist of insulin sensitivity (Si), glucose effectiveness (Sg), acute insulin response to
glucose (AIRg) and disposition index (DI), 20, 49 which can be determined by fitting of
glucose and insulin curves resulting from the FSIGT. Figure 1 describes the various
compartments used within the minimal model concept to quantify Si, Sg, AIRg, and
DI.20, 49-51 Five main equations are used to determine these values, all which can be
calculated using the minimal model. 20, 50, 51
Glucose effectiveness is an expression of the capacity for glucose to mediate its
own disposal independent of any insulin concentration change.20,49-51 This value can be
calculated using the following equation:
G’(t) = -(X + Sg) x G(t) + (Sg x Gb)
where G’(t) represents rate (min-1)of glucose clearance from plasma; X represents insulin
action or the ability for insulin to accelerate glucose disposal at increased levels; G(t)
represents plasma glucose concentration (mg/dL) at time t, where G(0) is the theoretical
glucose concentration at time 0; and Gb represents basal glucose concentration (mg/dL)
as maintained by hepatic production.20
Insulin sensitivity (L•mU-1•min-1) values are used to determine the capacity of
insulin to promote glucose uptake.20 Use of the following equations gives a Si value:
X’(t) = -p2 x X(t) + (p3 x [I(t) – Ib])
Si =p3 /p2
where X’(t) (min-2) represents the change in insulin action over time; p2 represents rate of
insulin action decline (min-1) ; X(t) stands for insulin action (min-1), or the acceleration of
glucose disposal associated with increased insulin concentrations; p3 represents the
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rate of insulin movement into the interstitial space (min-1); I(t) stands for insulin
concentration at time t (mIU/L); and Ib represents baseline insulin concentration
(mIU/L).20,49 Assumptions for this model are X(0) = 0 and [I(t) – Ib] = 0 if I(t) < Ib.20
Acute insulin response to glucose (AIRg), (mU • min • L-1) enumerates
endogenous insulin release in response to glucose presence,20 measured prior to
exogenous insulin administration.49 Calculation of AIRg can be done using the following
equation:
AIRg = ∫ [I(t) – Ib] x dt
where I(t) represents the insulin concentration at time t, and Ib stands for basal insulin
concentration.20 The above equation was integrated from 0 < t < 10 min in compliance
with the definition of AIRg proposed by Bergman.20, 51
The disposition index (DI), a quantification of pancreatic β cell responsiveness, is
a measure of absolute insulin action potential attributable to initial insulin response and
tissue sensitivity.49 The following equation can be used to calculate DI:
DI = AIRg x Si
Utilization of the minimal model allows for comprehensive analysis of the
components affecting glucose disposal, insulin signaling, and the relationship between
them.51 Practical applications for this method are often used in evaluation disease states,
supplemental effects from drugs or nutraceuticals, and impacts of acute exercise or
training.
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Figure 1: Diagram of the minimal model compartments. Variables correspond to
equations and definitions within the text.20
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Factors Affecting Insulin Sensitivity
Proper functioning of the physiological system can become compromised or
enhanced due to numerous factors including, but not limited to, age, breed, nutrition,
obesity, and exercise.20, 37, 41 Further understanding of the impact these parameters have
on glucose homeostasis within the horse can allow for manipulation of the system to
elicit a desired response. Although disruption of normal function can be detrimental,
knowledge of potential methods to alter glucose and insulin mechanics can have
implications in disease prevention or treatment, exercise performance, and overall animal
health.
Insulin sensitivity and glucose tolerance change over the course of a horse’s life.
During fetal development, foals in the second half of gestation have lower serum insulin
concentrations than mature horses with similar levels of circulating glucose.20 Pancreatic
β cell response to glucose increases with fetal age;52,53 prior to 230 days gestation
exogenous glucose administration does not elicit an insulin release. 53 Maturation of
pancreatic β cell function occurs over time, where insulin concentrations increase 24 to
48 hours post parturition,52,54 and increase to normal, mature levels at approximately 3
months after birth.55 Numerous studies across various models have shown that insulin
sensitivity decreases with age,44, 56-59 and the rate at which this decline occurs is
dependent on environment, diet, genetics, and several other factors.60 Potential agerelated changes to insulin sensitivity may be due in part to factors affecting the
hypothalamic pituitary adrenal axis, as changes in circulating levels of corticosteroids can
impact insulin effectiveness over time.61
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Differences in insulin sensitivity have also been noted across various equine
breeds. Ponies are typically less insulin sensitive than horses, 62 thereby having a slower
glucose disposal rate.63, 64 This characteristic makes pony breeds a good insulin
insensitive model for evaluating the effects of long term hyperinsulinemia or
hypyerglycemia on body systems and tissue function. 41, 64 Donkeys appear to have less
sensitivity to insulin than ponies or horses; after an oral glucose tolerance test, donkeys
and ponies have similar insulin concentrations, but donkeys had elevated glucose levels
as long as 6 h post glucose administration. 34 Draft breeds may have an improved insulin
sensitivity over light breeds, as displayed by the increased rate of glucose infusion needed
to maintain euglycemia for Belgian horses over Quarter horses during a clamp
procedure.65,66 More knowledge is needed to determine exact breed differences and
consideration should be taken when making conclusions based on insulin or glucose
measurements across breed types.
Dietary patterns play a key role in maintaining glucose homeostasis from many
different angles. Chronic positive energy balance can contribute to obesity, and insulin
resistance (IR), and despite the strong linkage between these two conditions,67 they can
occur independently of one another. 69 Management of nutrients in equine feedstuffs,
including fat, protein, and starch can prevent the negative repercussions associated with
overfeeding.
Insulin resistance (IR) is defined as the reduced cellular ability to respond to
insulin and transport glucose from the bloodstream into the muscle and other tissues. 22 In
horses, IR is commonly associated with equine metabolic syndrome (EMS), 20, 41, 69, 70
pituitary pars intermedia dysfunction, or Equine Cushing’s Disease, 37, 70 and some types
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of laminitis. 41, 71, 72 Chronic hyperglycemia resulting from IR can cause toxic effects on
the structure and function of many organs, including the pancreatic β cells.21 Asplin and
others demonstrated the ability to induce laminitis with prolonged infusion of insulin to
achieve a hyperinsulinemic, hyperglycemic status,30, 64 similar to the onset of laminitis
observed with EMS. One potential mechanism for glucose toxicity can be explained via
the formation of excess reactive oxygen species (ROS) which over time results in chronic
oxidative stress, decreased insulin gene expression, and impaired insulin secretion.73
Damage or exhaustion of the pancreas has also been demonstrated in other models,22 with
potential implications within equine metabolic syndrome.37
Concentrates are commonly fed to horses for many reasons. Ease of feeding
provides appeal to horse owners, while increased energy composition of the feed can be
applicable to the performance horse. Feeding concentrates as a supplement to forage
increases energy and nutrient consumption for horses with needs above maintenance
levels; however, overfeeding diets with high energy content can lead to obesity. In
horses, high fat diets can be utilized to increase caloric load without inducing a high
glycemic response67 and subsequent bouts of excitability.74 Enhancement of anaerobic75
and aerobic exercise performance76 has also been observed, however consideration must
be taken into the amount and necessity of fat supplementation. As the most energy dense
macronutrient (9 kcal/g), diets high in fat can cause weight gain and indirectly result in
IR due to increased adiposity.74 Excess fat can be stored intramuscularly, and may play a
role in reducing the tissue’s sensitivity to insulin,67 along with excessive feeding of other
nutrients.
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Excess protein within the diet is not only costly, but can negatively impact insulin
sensitivity.67 Several studies have shown that acute elevations in plasma amino acid
concentrations decreases glucose disposal during a hyperglycemic euglycemic clamp
trial,77-79 and excess leucine alone has minimized insulin mediated glucose uptake.80 A
possible mechanism for decreased glucose transport displayed in response to excess
amino acid presence may be due to the elevated inhibitory phosphorylation of IRS-1
achieved by mammalian target of rapamycin, or mTOR.81 IRS-1 inhibition thereby
decreases PI3K, and negatively impacts the recruitment of GLUT4 through this
pathway.81 Also, due to the glucogenic or ketogenic abilities of amino acids, and
therefore the ability for protein to contribute to energy storage, proteins should be fed at
maintenance requirements.82
High intakes of non-structural carbohydrates have been associated with
circulatory, hormonal, digestive, and metabolic changes,83 leading to the development of
various disorders such as IR, metabolic syndrome, and laminitis.84 Changes in postprandial glucose and insulin concentrations seen with diets high in starches and sugar are
much greater than those associated with diets of forage alone or those supplemented with
fat.83, 85, 86
Prolonged levels of elevated glucose concentrations not only induce obesity, but
also result in insulin insensitivity due to over-stimulation of the pancreas as well as tissue
unresponsiveness due to hyperinsulinemia. This decrease in glucose clearance from the
bloodstream causes conflicting signals to be sent through the tissues. On a circulatory
level, the body responds to the increased levels of glucose by stimulating more insulin
release; however, the tissues are not able to move glucose efficiently, and thus have to
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utilize other fuel sources. Often, this is manifested through fatigue or muscle wasting, due
to the lack of glycogen stores within the muscle and utilization of protein for energy,
respectively. Exercise along with dietary intervention can be implemented to counteract
and prevent this condition.

Effects of Exercise on Glucose Metabolism

Physical exercise can be an important adjunct in mediating the glucose-insulin
response in healthy, aged, and diseased animals. Similar to insulin, exercise increases the
rate of glucose disposal into the contracting skeletal muscle cells by utilization of a
different signaling pathway. A single bout of exercise has the ability to increase rates of
glucose usage 87, 88 and increase insulin sensitivity at the muscle level,89 with effects
lasting for hours after exercise has ended.90-92 Both short- and long-term exercise effects
on glucose uptake and disposal have important roles in relationship to chronic metabolic
control and acute regulation of glucose homeostasis.26
Acute Exercise
In the contracting muscle, the need for metabolic fuel is partially met though an
increase in glucose uptake and utilization. Initially, this phenomenon was displayed in the
masseter muscle; as chewing occurred, venous outflow showed decreased glucose
concentration, suggesting a mechanism for glucose uptake during contractions.93 Over
time, more information was collected to suggest potential methods for this increased
disposal. Evidence has been found to suggest that in conjunction to increased glucose
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uptake during exercise94, 95 acute exercise results in increased insulin sensitivity restricted
to the exercised muscles.
The major mechanism by which glucose disposal is increased during exercise is
through the recruitment of GLUT4. The exercise-induced translocation of this transporter
is due to an increase in recruitment in association with the non-junctional transverse
tubules upon contraction, rather than an increase in amount of GLUT4 protein present in
the cell, or an increase in other GLUT isoforms.26,96-98 Although insulin concentrations
during exercise are typically reduced, 67 increased blood flow to the muscle during
exercise may also increase the amount insulin presented to the muscle receptors,
therefore causing the increased translocation of GLUT4.99 The effects of exercise and
insulin can produce additive effects on GLUT4 movement,100-102 yet independent
function is also displayed, suggesting the existence of different intracellular pools of the
transporter that respond to each respective stimulus.99, 103, 104
Post exercise increases in insulin sensitivity are typically characterized by
elevated rates of basal and insulin mediated glucose uptake for several hours.101, 105
Although the exact mechanisms in this response are unknown, replenishment of muscle
glycogen stores, influence of endocrine mechanisms, and serum contents may elicit these
effects.26 Degree of glycogen depletion can mediate the rate and duration of muscular
glucose disposal after exercise due to the need to increase glycogen stores for the next
bout of exercise.26 Insulin signaling is not altered by exercise as a single bout does not
impact insulin receptor affinity, or tyrosine-kinase receptor signaling;106-108 however,
increased presence of the hormone due to increased circulating levels of glucose from
hepatic gluconeogenesis elicit the glucose disposal. Resulting hypoxia from exercise
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markedly amplifies glucose signaling in the muscles, by use of a signaling pathway
which bypasses the insulin receptor, IRS-1, and the subsequent activation of PI3K in
hypoxic conditions.109, 110 Utilization of these mechanisms can be beneficial to the horse
with hyperglycemia, as exercise can provide a transient decrease in blood glucose levels.
Repetition of exercise bouts can elicit a larger, more prolonged response which can be
instrumental in management of IR and long term improvement of glucose tolerance.
Exercise Training
The beneficial effects of exercise training may be due to the overlapping short
term effects of each individual bout of exercise along with changes in gene transcription
levels. Increased mRNA levels of insulin receptor, IRS-1, MAP kinase,111 and GLUT4
have been observed after exercise training in both healthy and insulin resistant models.112
Expression of the GLUT4 gene is also seen in trained athletes, in association with
increased in insulin mediated glucose disposal.113, 114 Comparison of an animal’s
response to an acute bout of exercise pre and post training can provide a comprehensive
picture of the alterations seen to glucose metabolism. Implications for this type of
program can be useful to determine if long term training effects can be influential in
addressing symptoms associated with IR horses.
The Exercising Equine Model
Although evaluations of the effects of exercise on metabolic parameters are useful
in determining the horse’s ability to handle and recover from acute bouts of exercise,
determination of overall body status changes in an exercising model are also important.
Exercise can be performed at varying intensities, and monitored using numerous
parameters including heart rate (HR), length of exercise, and time spent at each gait. 82
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Understanding the physical and metabolic demands of low, moderate, and high intensity
exercise can be utilized to provide insight on the effects of supplementation.
Workload categories for horses have been established by evaluating the
relationship between oxygen consumption and energy expenditure. Amount of energy
utilized during exercise is dependent on the duration and intensity of the exercise bout.82
While duration is easy to quantify, intensity is often difficult to measure, as numerous
factors can influence this parameter including ground resistance, incline, speed of
movement.82 In regard to performance, degree of collection, height of jumps, and weight
pulled or carried can greatly impact the workload performed by the horse,82 and thereby
alter the metabolic demands of the body.
Oxygen utilization and heart rate are closely correlated, therefore making it
possible to determine approximate energy expenditure from heart rate.115 Due to this
relationship, heart rate can be used to assess the workload performed by the horse, and is
an integral tool utilized in the development of exercise programs. Heart rate during
exercise is measured in order to properly evaluate the workload, as mean heart rate is
used to determine exercise intensity. Light, moderate, heavy and very heavy exercise
categories encompass varying athletic events, and tasks equine athletes are asked to
perform, with mean heart rates for each bout at 80, 90, 110, and 110-150 bpm,
respectively.83 Duration of exercise is also important to consider, as the amount of time
spent at a given level of work can greatly alter energy expenditure and other factors
including reactive oxygen species (ROS) generation, which can induce changes both
locally and systemically.
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Effects of Exercise on Oxidant Status

Aerobic metabolism, the body’s most efficient means of energy production,
utilizes oxygen as the final electron acceptor in mitochondrial electron transport chain
(ETC). Although most oxygen that enters the body is utilized in this manner, a small
portion is susceptible to enzymatic alteration, direct chemical reactions, or modification
by the cytochrome P450 superfamily, which utilizes oxygen for substrate oxidation.1, 116
Combined with the oxygen that has not been fully reduced to water in the ETC, which
amounts to approximately 1-2% of total oxygen intake, these compounds are referred to
as reactive oxygen species (ROS).117 Accumulation of these compounds can be utilized
for signaling or inflammatory responses within the body; however, prolonged elevated
amounts can cause detrimental effects to lipid membranes, proteins, or nucleic acids.
Oxidant status in the body is a constantly changing balance between reactive species and
the defense systems utilized to keep their effects at bay. Conversion of ROS into
effectively neutral compounds via the anti-oxidant defense system allows the body to
cope with increased levels of ROS, and prevents against some of the damaging effects of
these molecules on cells.1, 116 Evaluation of this balance can provide insight to whole
body oxidant status, as well as the degree of damage resulting from ROS.
ROS Production
Formation of ROS can occur in a multitude of different ways, including both
radical and non-radical derivatives of oxygen. Molecular oxygen in the ground state is a
bi-radical, containing two unpaired electrons in the valence shell, sharing the same
spin.118 This similarity causes oxygen to react with one electron at a time. A free radical
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is an independent species with one or more unpaired electrons, formed by the loss or gain
of a single electron. These molecules tend to be highly reactive, either accepting or
donating electrons rapidly in order to achieve a more stable state of being. Reactive
oxygen species is an inclusive term used to describe some free radicals, such as
superoxide and hydroxyl, but also include some non-radicals such as hydrogen peroxide
and hypochlorous acid.1 All radicals are ROS, however not all ROC are radicals, yet their
reactivity allows them to easily strip electrons from other molecules, producing another
free radical in the process.1 Generation of ROS can be seen throughout the cell, however
the most important source of production is the ETC.
During normal metabolic function, the mitochondria utilize different states of
respiration. Alterations in substrate availability and metabolic demands impact the
changes between the different states of respiration. State 3 and 4 of respiration are
commonly examined to further understand the impact of the ETC on cellular metabolism
and oxygen utilization.1 State 3 represents the maximal oxygen consumption rate needed
to meet metabolic ATP demands, whereas state 4 respiration is associated with
maintenance ATP production costs.116 State 4 is also characterized by low ADP amounts,
as the body is able to keep up with energy production; however, despite the lower flow of
electrons through the chain, this state produces an abundance of superoxide radicals. This
production occurs due to leakages caused by improper function of b-type cytochromes,
like ubiquinone, which transports electrons from complex I and succinate to complex III,
complex I constituents, and overall damage to mitochondrial organization.116 Other
methods of ROS production include xanithine oxidase, electron leakage from nuclear or
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microsomal membranes containing cytochrome b5 and P-450, inflammatory response
leading to increased activation of NADPX oxidase,1 along with many others.
Functions of ROS
Through the conversion of oxygen into water, various intermediates are formed,
most of which contribute to the ROS pool. Most commonly superoxide, the hydroxyl
radical, and hydrogen peroxide are measured due to their prevalence within this
conversion and their role within the body. Despite the negative connotation associated
with ROS, a certain level of intracellular production is necessary to activate growth,
differentiation, proliferation and apoptotic programming.119 Superoxide, a highly reactive
molecule, is often formed first from leaky channels within the ETC, which can then be
dismutated spontaneously or by superoxide dismutase (SOD) into hydrogen peroxide.120
Hydrogen peroxide is a non-radical and a weak oxidant, with a long half-life, permitting
diffusion across cell membranes, and interaction with many different cellular molecules
allowing for the activation of a variety of signaling pathways.2 Redox regulation, such as
the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) transcriptional
activators, rely on signaling from ROS to relieve inhibition from IkB proteins, thereby
allowing for transcription of several antioxidant enzymes including copper-zinc and
manganese SOD.119 Mitochondrial biogenesis and metabolic changes seen in response to
exercise may be coordinated through ROS signaling of transcription factors and
coactivators.119 Although the exact role of ROS in many signaling pathways is unknown,
measurement of ROS activity and presence is critical to understanding the function of
these molecules.
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Detection Methods
Measurement of ROS can be challenging, due to their highly reactive nature and
relatively short time of existence. Direct and indirect detection and fingerprinting can be
used to determine the presence of ROS, measure the concentration of specific ROS
species, and assess damage caused to cellular molecules. Direct measurements can be
made through electromagnetic spin resonance used to detect the presence of an unpaired
electron using a magnetic field. This method can also be utilized to detect changes in
transition metal ions used in ROS production.121 Although this method can be used in
vivo, it has low sensitivity, therefore making it difficult to detect highly reactive radicals.
Spin trapping is often used to overcome this, as it is highly sensitive. Reactive oxygen
species are allowed to react with selected molecules to produce a more stable compound
that can be detected and measured reliably.122 When used in combination with one
another, these methods can provide a big picture view of ROS within an in vivo model.
Indirect methods of detection are used to quantify their concentrations, with
various methods applied dependent on the ROS to be evaluated. Superoxide detection
methods include reductions of nitroblue tertazolium or cytochrome c, and oxidation of
lucigenin.121 Unfortunately, reduction methods display low specificity and sensitivity, as
many compounds besides superoxide can reduce these molecules while lucigenin
oxidation is subject to artifact production, and care should be taken when analyzing
results from these methods.121 Hydrogen peroxide can be measured reliably using
horseradish peroxidase assays utilizing a specific reaction to produce a fluorescent
product for detection. Also, probes for tissue detection of ROS can be used; however,
caution should be taken to ensure accumulation of the probe does not occur in a particular
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cell compartment.122 Concentration of the hydroxyl radical is most commonly determined
using the tryptophan reaction or utilizing the conversion of DMSO to methane gas and
calculating the rate of change relative to radical presence. Hydroxyl radicals are detected
using the tryptophan method by measuring the formation of 5-hydroxytryptophan
luminescence induced by multiphoton excitation.123
Fingerprinting is an effective means utilized to determine the reactions of ROS
with cellular components due to their characteristic end products. Proteins, lipids, and
nucleic acids are the main targets for ROS damage. Damage to proteins is primarily
quantified via amino acids with reactive carbonyl groups as they are the most easily
measured experimentally.122 Measurement is determined by the interaction of oxidized
protein molecules with dinitrophenylhydrazine, utilizing a fluorescent or radiochemical
method of analysis. Although this method is reliable, the tissues are susceptible to
proteolysis and other altering reactions that may skew results.122 Lipid peroxidation is the
most widely measured form of ROS fingerprinting, as many of the assays are easy to use
and provide good results. Loss of unsaturated fatty acids can be measured through high
performance liquid chromatography, while peroxide assays can be conducted for
glutathione peroxidase, cyclooxygenase, and many more.122 End-product measurements
are also used to gain a broader view of overall lipid peroxidation, such as thiobarbituric
acid reactive substances assays. Nucleic acid damage can be quantified using purine and
pyrimidine base modification via the detection of 8-hydroxydeoxyguanosine, formed in
the presence of a hydroxyl radical.122 Strand breakage can also be quantified, as oxidation
of the strands will cause cleavage, resulting in detectable fragments. Deoxyribose
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oxidation is not easy to measure, and should not be used as a sole indicator of damage,
since multiple products are produced.
Although ROS production is necessary within the body for proper signaling and
other homeostatic functions, excessive production can elicit damaging responses.1
Potential mediation beyond naturally occurring defense mechanisms in the body can be
employed to buffer or prevent these changes. From an exercise perspective, reduction in
excessive ROS production and damage could result in increased performance due to
decreased insult to cellular components.119 Phytochemicals, compounds which naturally
occur in plants, may have an impact on overall health and are commonly fed to horses as
a supplement in hopes of preventing ROS damage.4 Although some of these compounds
are used extensively, knowledge of their function, efficacy, and safety are limited, and
require further research.

Resveratrol

Naturally, plants synthesize a wide array of compounds which have potential health
benefits when eaten. Resveratrol (trans-3, 4’, 5-trihydroxystilbene, figure 2), a
phytocompound found most commonly in grapes, red wine, yucca, and peanuts, 4-6 has
been found to act as a powerful antioxidant and anti-inflammatory agent, along with
having beneficial effects against ageing and metabolic diseases.6 Administration of
resveratrol has been shown to cause a reduced amount of edema,123 increased muscle
strength and endurance,8, 124-127 along with protecting skeletal muscle from the deleterious
effects of oxidative stress through alterations in metabolism8, 123, 125-127 and reduced
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protein catabolism.8, 124-127 Additionally, within skeletal muscle, resveratrol has been
found to increase insulin stimulated glucose transport9 and improve glucose
homeostasis.8 By limiting the detrimental effects on metabolism combined with
reductions in tissue injury, increased exercise performance may then be expected to occur
in response to resveratrol supplementation in horses.
Synthesis and Structure
Resveratrol is a phytoalexin, meaning synthesis of the compound can be induced
by microbial infections, ultraviolet radiation and exposure to ozone.128 Grapes are the
primary source of naturally occurring resveratrol,129 with concentrations of the compound
is found in the leaf epidermis and the skin of grape berries, but not within the flesh. 128-130
Stilbene synthase, the terminal enzyme in the production pathway is activated in response
to exogenous stress factors, ultra-violet radiation and chemical signals from
pathogenic fungi.130 Levels of resveratrol peak approximately 24 h post stress exposure,
and decline 48-72 h later due to the activation of catabolic stilbene enzymes.130
Concentration of resveratrol in grapes is dependent upon maturity and variety of the
grape, along with duration of stress exposure.Grape leaves reach concentrations ranging
50-400µg/g fresh weight, while fresh grape skin content ranges 50-100µg/g .128
Resveratrol can occur in multiple forms, both of which are counted in these
concentrations.
Resveratrol exists in two isoforms, trans- and cis-, each having their own
properties and functions. Although the cis conformation may possess numerous health
benefits, it is not widely studied at this time.131 Plants can also synthesize stillbenoid
glucosides, forming cis- and trans- resveratrol 3-O  glucoside,129 which when cleaved
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can produce a free glucose molecule. Resveratrol can also be obtained through organic
synthesis; trans-resveratrol is most often formed first, and when exposed to ultra violet
irradiation changes into the cis conformation.130 Research on the biological properties of
resveratrol such as bioavailability and function were limited until the compound could be
synthesized, as pure extraction from the grape skin and leaves is difficult to achieve.
Bioavailability and Metabolism
Bioavailability of a nutrient is defined by the amount available to the target tissue
after administration, including absorption, distribution, and metabolism of the compound.
Resveratrol absorption from the intestine is rapid,132-135 allowing for distribution to
various organs, primarily the liver, kidneys, brain, lungs, and muscle.135, 136 Absorption of
resveratrol is not greatly impacted by the vehicle in which it is administered. In humans,
resveratrol is most commonly consumed in red wine, but can also be found in grape juice
and vegetable homogenates.137 Although resveratrol content can vary depending on
previously mentioned variables, a previous study held resveratrol concentration constant
among different matrices to determine absorption rate.137 The matrix used to deliver the
compound does impact total resveratrol when administered utilizing the different forms
of adminsitration.137 In order to travel through the body, resveratrol must be bound to
protein or become conjugated, primarily into resveratrol-3-glucoronide or resveratrol-3sulfate, to remain at elevated concentrations in the serum due to its low water
solubility.138 Albumin is thought to be one of the main plasma protein transporters of
unconjugated resveratrol due to its physical properties allowing it to bind to hydrophobic
compounds. 139, 140 The compound is also shown to interact with lipoproteins in a lipid
concentration dependent manner.141 The efficiency of any compound is greatly related to
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Figure 2: Trans-resveratrol (trans-3, 4’, 5-trihydroxystilbene).129
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its selectivity and affinity to protein transporters, which can aid in tissue recognition of
the molecule.
Upon absorption, delivery of protein bound or conjugated resveratrol to the
tissues occurs, with the liver having the highest accumulation of the compound.128,136
Uptake of resveratrol into the liver occurs via passive diffusion, and carrier mediated
transport. Utilization of radiolabeled resveratrol allowed for the examination of time,
dose, and temperature dependencies of resveratrol uptake into the organ, finding that
carrier facilitated transport is primarily used to allow for efficient and specific uptake of
resveratrol.142 The liver seems to be a reservoir of resveratrol and its conjugated
metabolites, resulting from metabolism both in the intestine and the liver. The function of
this pool is not entirely understood; however, it is thought to be partially responsible for
the prolonged effects of resveratrol after a bolus dose. Detectable levels of resveratrol can
occur as early as 15 min post resveratrol administration, with peak concentrations
occurring 30 min after dosage.136 Although free resveratrol content begins to decline 1 h
post-dosage,143 resveratrol metabolites remain in the circulation for longer periods of
time. A second resveratrol peak occurs approximately 6 h post administration, due to
enteric recirculation of conjugated metabolites. The presence of these metabolites is
known to aid in the elevation of detectable levels of resveratrol in the blood over time,128,
136, 144

which may contribute to the efficacy of resveratrol within the body; however, the

exact function of these structures remains to be determined. It is important to note the
effects of resveratrol and the time course during which the free and conjugated forms can
be detected may be dose dependent, which will be later discussed in detail.
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Removal of resveratrol from the body is accomplished mainly through renal
excretion. Decreasing concentration of radiolabelled resveratrol metabolites in the
kidneys strongly suggests their primary role in elimination of these compounds from the
body.133, 134 Some elimination may occur through biliary binding pathways, although
minimal research has been conducted in this area.128 Resveratrol-3-sulfate and
resveratrol-3-glucoronide are found in the urine of rodents and humans;135,143 however,
species variation should be taken into consideration, along with differences due to dose
rate and concentration. Free resveratrol has not been found in murine or human urine,143
suggesting that the majority of free resveratrol is either utilized by the peripheral tissues
or conjugated and stored by the liver or excreted.
Functions
Resveratrol is currently known for its antioxidant, anti-inflammatory, anti-cancer
and chemopreventative abilities. Interest in resveratrol began when an inverse correlation
was found between red wine consumption and cardiovascular disease occurrence.129 The
compound was first thought to be the biologically active ingredient in red wine in
1992,145 causing extensive research into the effects of resveratrol within the body.
Currently, resveratrol is known to impact numerous mechanisms and pathways within the
body, including inhibition of lipid peroxidation, free-radical scavenging, alteration of
eicosanoid synthesis, modulation of lipid metabolism, improvement of insulin sensitivity,
anti-inflammatory activity and estrogenic activity.9,128-131 For the purpose of this review,
lipid peroxidation, modulation of lipid metabolism and improvement to insulin sensitivity
will be the primary focus.
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Resveratrol prevents the peroxidation of membrane lipids by ROS.129, 146, 147
Resveratrol acts as a scavenger of free radicals, preventing the oxidation of membrane
lipids.146 Maintenance of structural integrity of the plasma membrane is crucial to proper
cellular function, and can have detrimental effects on exercise performance. Preventative
effects are not limited to the muscle cells; it has been shown that resveratrol has
prevented damage due to peroxidative stress in dopaminergic neuronal and hepatic
cells.146, 147 The compound has also been found to prevent metal induced lipid
peroxidation within microsomes and low-density lipoproteins (LDL).148 Alterations in the
conformation of LDLs can increase the amount of circulating fatty acids in the
bloodstream, due to structural changes in apo B, thereby affecting catabolism by the B/E
receptor system,121 aiding in the predisposition of the animal to numerous metabolic
diseases.
Modulation of lipid metabolism can also occur due to resveratrol
supplementation. Resveratrol has been shown to increase silent information regulator 2
homolog (SIRT) 1 and peroxisome proliferator -activated receptor (PPAR)- coactivator1 (PGC1) in muscle,123 resulting in an altered metabolism displaying an increased
sensitivity to insulin, along with a preferential switch to fat as a fuel source.149 Increases
in fatty acid transporter content, PPAR- pathway activation, and fat oxidation enzymes
are responsible for this shift. The glucose sparing effect of resveratrol allows for more
glucose to be stored as glycogen, and a decrease in fat available for deposition in the
adipocytes. Reduction in circulating fatty acids in the blood stream combined with
improved insulin sensitivity makes resveratrol a potential mediator for type 2 diabetes in
humans, and a potential area of interest for equine metabolic syndrome.
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Resveratrol has been shown to improve insulin resistance via enhancement of
enzyme activity involved in glucose metabolism, along with increasing the insulin
sensitive cell’s ability to respond to the hormone. In a streptozotocin-nicotinamideinduced diabetic rats, resveratrol supplemented orally at 5mg/kg BW for 30 days was
able to alter activities of key carbohydrate metabolism enzymes such as hexokinase and
pyruvate kinase, which returned back to normal concentrations, allowing for normal flux
of the substrate through this catabolic pathway.150 Reduction of circulating glucose is
achieved by enhancement of GLUT-4 translocation, perhaps due to resveratrol’s actions
on PGC-1.151, 152 In mice, resveratrol supplementation at 400mg/ kg BW daily increased
levels of PGC-1 acetylation, leading not only to an increase in glucose transport, but
also to an induction of oxidative phosphorylation genes and mitochondrial biogenesis.152
Increasing the cells ability for glucose uptake and metabolism can aid to alleviate
hyperglycemia along with ensuring substrate availability in the cell for utilization and
storage.
Increased circulating levels of ROS, excessive circulating free fatty acid levels,
and hyperinsulinemia, can all cause oxidative stress, resulting in chronic inflammation,
insulin resistance, and decreased exercise performance.29 Resveratrol acts to diminish
oxidative stress via induction of mitochondrial MnSOD expression and activity.153 A
potential mechanism of action for this result begins with resveratrol increasing the SIRT
1 to NAD+ ratio, leading to an increase in FOXO3, resulting in increased MnSOD
activity. Other enzymes, such as CuZn SOD, glutathione peroxidase, and catalase display
either remain the same or decrease in activity the presence of resveratrol
supplementation.153
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Dosage
Despite the extensive research conducted across murine and human models, an
effective dose for resveratrol has yet to be established. Administration rates,
concentrations, and durations are widely varied, making it difficult to determine
appropriate means through which beneficial effects can be seen. Fresh grape skin
contains 50-100mg resveratrol/g,154 making the content of naturally occurring beverages
containing the skin vary greatly as well. In red wine, the range of detectable transresveratrol spans from non-detectable levels to 14.3mg/L (62.7M), with reported health
benefits seen at average levels, 1.9 + 1.7mg/L (8.2 + 7.5M).130 During early resveratrol
trials, wine of a known content was used as the main method of dosage. Even then,
duration and concentration of supplementation varied greatly; 86g resveratrol/kg BW
for a single dose, or 43g resveratrol/kg BW once daily for 15 days.132-134 The trend
continues through much of the literature utilizing a more “natural” form of resveratrol,
and has transcended through present day.
The development of organic synthesis of trans-resveratrol opened the door to
further research on the compound without concern of competition or conflicting results
due to competition of other flavinols present in wine. Despite this advancement,
resveratrol could then be administered in greater doses, over greater time periods, along
with the option of injectable administration. Intragastric administration to mice has been
supplemented from values ranging to 0.228/kg BW to 60 mg/kg BW, making it difficult
to elucidate the appropriate dose on a weight basis.133, 135, 149 In human studies,
supplementation levels have been reported at 0.03mg/kg BW to 0.35mg/kg BW, with
many other values in-between.137 Duration of supplementation also varies tremendously;
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some literature touts the benefits of a loading dose of high concentration, followed by a
lower maintenance dose, while others remain at a specified concentration over time.
Single dose administration seems to be utilized only during trials for which absorption,
metabolism, or clearance are the primary areas of evaluation.
Resveratrol in the Equine Industry
Regardless of level, resveratrol supplementation appears promising. Many nutritional
supplements fed to performance horses today contain resveratrol. Lack of regulation in
this area of equine nutrition allows for extreme flexibility in the content of each
supplement and the claims made in regards to their suggested benefits to the horse. Many
companies have begun to incorporate resveratrol into their products at varying
concentrations, usually in conjunction with other compounds with suggested health
benefits. Utilization of this compound in the athletic horse can lead to a decrease in ROS
damage, therefore decreasing the detrimental effects seen with prolonged exercise at
varying intensities.
Along with its popularity within the equine performance horse industry, resveratrol
also has a potential role for the metabolic syndrome animal. Maintenance of these
animals is often difficult, with the primary goal of treatment to reduce BW and return
insulin sensitivity and glucose tolerance to a normal level to prevent laminitis and
worsening of the condition. Due to the positive benefits in other models, resveratrol
supplementation may be beneficial to the treatment of this condition by increasing
glucose transport, shifting to fat as the preferred metabolic fuel source, and increasing
oxidative capacity through mitochondrial biogenesis.152
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Despite the current popularity and the vast potential uses for resveratrol within the
equine industry, no published research is currently available within an equine model.
Without this data, speculation and testimonials from consumers are used to evaluate the
function of resveratrol within the horse and market the compound to the equine industry.
Evaluation of both an athletic and EMS model are needed to fully elucidate the effects of
resveratrol within the horse. A better understanding of how resveratrol contributes to
equine health and potential performance could be obtained by evaluating various
parameters relating to glycemic response, levels of oxidative damage, and inflammation,
with consideration given to the findings of previous studies in other models.
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STATEMENT OF PROBLEM, OBJECTIVE, AND HYPOTHESIS
In both human and rodent models, research has been conducted to determine the
effects of resveratrol. Diets high in this phytocompound are synonymous with good
health, with applications in various models and disease states. Specifically, resveratrol
has been found to have both antioxidant and anti-inflammatory properties, while at the
same time improving cellular glucose dynamics. While numerous equine performance
supplements contain resveratrol, no research has been conducted utilizing an equine
model.
Therefore, the objectives of the proposed study are to utilize a mature, athletic
horse model to (1) examine the ability of resveratrol to act as an antioxidant molecule to
protect the body against oxidative damage and lipid peroxidation, (2) determine the effect
of resveratrol supplementation on basal plasma insulin and glucose concentrations, as
well as glucose and insulin dynamics during a frequently sampled glucose tolerance test.
The hypotheses of this study were that resveratrol supplementation would (1)
improve oxidant status within the moderately exercised equine model by reducing the
level of lipid peroxidation within the body (as measured by TBARS), and (2) increase
insulin sensitivity and glucose tolerance as displayed by the Minimal Model parameters.
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CHAPTER II: MATERIALS AND METHODS

The West Virginia University Animal Care and Use Committee approved all
methods and procedures used in these experiments.
Animals and Diet
Six, healthy, fit, mature Quarter Horse geldings (equus caballus) were used in this
study (10 + 1 yr). The Quarter Horse breed was used due to its popularity within the
United States, versatility among various performance events, and industry impact due to
the large population within the targeted marketing group. Prior to use for this project, all
horses were used for the Equestrian Technology course offered by West Virginia
University, where they were exercised lightly 3 to 4 times per week for approximately 1
hour per week, mainly at the walk and trot, by riders of all experience levels. All horses
began the study with a body condition score (BCS) of 5.5 + 0.5, which was maintained
through the duration of the trial. Body weights (BW) were taken on day 0, and 10, and
14 of each treatment period and are further described later.
Horses were brought in one week prior to the start of the study to allow for dietary
adjustment from pasture. Geldings were housed in 3.05 x 3.05 m box stalls at West
Virginia University Reedsville Experiment Farm, with turnout in pairs 1 h per day in a
sand arena, to ensure dietary control through the course of the study. Horses were
offered a commercially available concentrate ration (Southern States Legends Show and
Pleasure Pellets, Richmond, VA) at 0.5% BW and grass hay (West Virginia University
Agronomy Farm, Morgantown, WV) at 1.75% BW divided into two feedings daily. The
ration was formulated to meet National Research Council82 recommendations for mature
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horses in moderate work. Hay and concentrate samples were analyzed by a commercial
laboratory (Equianalytical laboratories, Ithaca, NY). A summary of feed analyses can be
found in Table 1. On an as-fed basis, concentrate provided 2.75 Mcal/kg and hay
provided 1.97 Mcal/kg. All feedstuffs were weighed prior to feeding, and any refusals
were recorded to determine actual daily intake. Horses were provided ad libitum access
to water. Geldings were accustomed to the barn, and general laboratory procedures.
Resveratrol Supplementation
Horses were assigned to treatment groups using a Latin Square crossover design
(Figure 3). Treatment groups included control (C, no supplementation), low
supplementation (L) of 2.5g trans-resveratrol once daily, and high supplementation (H) of
5g trans-resveratrol once daily.
Resveratrol is generally regarded as safe (GRAS). The supplement was compounded
(Equithrive, Lawless, KY) with a concentration of 1g of 99% pure micronized resveratrol
per 10g polyethylene glycol-based paste, therefore horses received a total of 25g or 50 g
of product in the L and H dosage groups, respectively. The resveratrol micronization
process ensures that 90% of particles measure less than 10 m, and when combined with
polyethylene glycol, makes the compound more water-soluble and thus should increase
bioavailable. These levels of supplementation reflect values currently used in rodent and
human research, calculated on a basis for a 500 kg average horse to receive 5mg/kg and
10mg/kg. Metabolic BW (MBW, defined as BW(0.75)) was calculated 82 to ensure
supplementation levels were adequate in relationship to metabolism of the compound for
species used in previous research. Average BW for each species was determined as; rat:
230 g,155 mouse: 20 g,155 human: 70 kg,156 horse: 500kg.82 When compared on a MBW
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Table 1: Nutrient analysis (DM basis, Equi-analytical, Ithaca, NY) for hay and
concentrate, fed at levels in accordance with NRC recommendations, to mature Quarter
Horse geldings performing moderate intensity exercise to for a total of 9 weeks; 1 week
acclimation prior to study, 3 periods of 2 week supplementation, and 1 week washout
periods in between treatments.
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basis, dosages utilized for this study are applicable to those commonly seen in literature
for other models.
Supplementation was conducted over 14 d, with a 7 d washout period in between
each treatment. During the treatment period, horses were moderately exercised three
times per wk as per the protocol detailed below.
Exercise Protocol
In order to assess the effect of resveratrol on an exercising conditioned model,
horses maintained a moderate level of activity through the study. Turnout was allowed
for ~2 h per day during treatment and washout periods. Horses were exercised 3 times
per week for 60 min, with at least one day of rest in between exercise bouts. In
accordance with the NRC, moderate intensity exercise is defined as 3-5 h per week, with
a mean heart rate of 90 beats/min, during which 30% of exercise time should be spent at
the walk, 55% at the trot, and 10% at the canter.82 Using these guidelines, the following
exercise protocol described in Table 2 was followed for the duration of the study, with a
total time at the walk, trot and canter being 18, 30, and 12 min, respectively.
An equine heart rate monitor (Polar Equine, Lake Success, NY) was utilized to
monitor heart rate during exercise bouts. Heart rate was monitored starting
approximately 10 min prior to exercise to allow acclimatization of the system, and to
ensure the horse was at rest before starting to work, and continued through the entire
exercise set. Gait speed was adjusted to maintain heart rate within the target range. All
horses were ridden by a set of riders with similar skill sets, and all exercise bouts were
overseen by one individual to ensure continuity through the study. All horses remained
sound through the course of the project.
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Figure 3: Latin square crossover design used to rotate control (C, no supplementation),
low resveratrol supplementation (L), and high resveratrol supplementation (H) between 6
mature Quarter Horse geldings during 3 treatment periods of 2 weeks each. Between each
treatment period a 1 week washout period was allowed to pass before the next treatment
was administered.
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Table 2: Exercise protocol designed to mimic moderate intensity exercise in accordance
with NRC guidelines.
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Blood Samples and Muscle Biopsies
Blood samples were collected into sodium heparin tubes (Vacutainer, Franklin
Lakes, NJ) on d 0 and 14 of supplementation within 24 h of an exercise bout for later
analysis of TBARS concentration. Samples were pulled, placed immediately on ice, and
transported to the West Virginia University Main Campus for further processing.
Samples were centrifuged at 3000 x g for 1 mi n, and stored at -2

C until analysis.

Muscle tissue biopsies were collected on day 0 and 14 of each treatment period. A
Bergstrom biopsy needle was used to collect tissue samples from the middle gluteal
muscle.157 All geldings received Xylazine (0.5mg/kg) sedation and were given Lidocaine
anesthesia (8-10cc of 20mg/50mL concentration) at the biopsy site ~10 minutes prior to
sampling. Samples were dissected into 0.25cm pieces, immediately flash frozen in liquid
nitrogen, then stored at -80 C until later analysis for resveratrol concentration (results not
shown).
Frequently Sampled Intravenous Glucose Tolerance Test (FSIGT)
All horses were subjected to a FSIGT on d 10 of resveratrol supplementation
during each treatment period. Concentrate and hay feedings were withheld for the
duration of the test, and at least 12 h had passed since the last feeding. The protocol for
this test was determined from previously published methods, described below.20
Geldings were weighed using an electronic scale and catheterized (Abbocath, 14g,
5.5 in, Abbott Laboratories, Abbott Park, IL) using aseptic technique and Lidocaine
anesthesia between 0730 and 0830. Horses were paired randomly to allow for test
staggering. Baseline blood samples (~25ml) were collected 30 minutes prior to the start
of each test, at approximately 0900, 0930 and 1000, respectively. A glucose bolus of
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0.3g/kg BW (dextrose solution, 50%, Phoenix Pharmaceutical, Inc, St. Joeseph, MO) was
infused via catheter over a 2 min period. Twenty min after the glucose dose, an insulin
bolus (Humulin R, Williow Birch Pharmaceutical, Inc, Taylor, MS) of 30mIU/ kg of BW
was administered via catheter. The primary function of the insulin bolus was to
administer a physiological, not pharmacological, dose of insulin, to prevent prolonged
hyperglycemia, and prevent hypoglycemia.20
The test was conducted over ~3 h, during which blood samples (~25ml) were
collected at -30, 0, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 16, 19, 22, 23, 24, 25, 27, 30, 35, 40,
50, 60, 70, 80, 90, 100, 120, 150, and 180 min post glucose administration. Between
each sample, the catheter and extension set were flushed with 15-20cc heparinized
normal saline to prevent clot formation within the line, and avoid contamination of
successive samples. Samples were placed in serum separator and sodium
fluoride/potassium oxalate tubes (Vacutainer, Franklin Lakes, NJ), and stored on ice until
centrifugation at 3000 x g for 10 min. Sodium fluoride/potassium oxalate additive was
used to prevent further glycolysis in samples to be later assayed for glucose
concentration. Aliquots were taken from both tubes, and stored in microcentrifuge tubes
at -2

C until analysis. For insulin concentration, serum aliquots were measured in

duplicate via a commercially available radioimmunoassay (Coat-A-Count, Siemens, Los
Angeles, CA), as directed by the package insert. After the samples were decanted, they
were placed in a gamma counter (Perkin Elmer, Wallac 1470 Wizard Auto Gammacounter, Waltham, MA), where each replicate was counted for 1 min. Plasma glucose
was measured in duplicate using a commercially available kit (Autokit Glucose, Wako
Diagnostics, Richmond, VA) adapted to a 96 well plate. In brief, 9µL of sample,
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standard or control were pipetted into a 96 well plate. Standards provided in the kit were
diluted to include concentrations which more accurately reflect those seen in horse
blood.158 Then, 3

L of buffer solution was added to each well, followed by 2 mi n

incubation at 37 C. The plate was then read on a UV spectrophotometer (Spectramax
Plus 384, Molecular Devices, Sunnyvale, CA). Each of these kits have been previously
validated for use in the horse.2, 158 The accepted replicate coefficient of variation was 5%
and 10% for glucose and insulin concentrations, respectively.158
Thiobarbituric Acid Reactive Substances (TBARS)
Plasma samples collected on d 0 and 14 of each supplementation period were
assayed for presence of TBARS. A commercially available kit (TBARS microplate assay
kit, Oxford Biomedical Research, Oxford, MI) was used in accordance with the kit insert.
In brief, 25
by 25

L of standard or sample was pipetted into a microcentrifuge tube, followed

L of indicator solution or acid reagent. Samples were incubated at 5 C for 15

min, then centrifuged at 100xg for 15 min, and loaded onto a 96 well plate. Absorbance
was read at 532nm (Flexstation3, Molecular Devices, Sunnyvale, CA). Samples
containing acid reagent were used as a blank, and were subtracted from those containing
indicator solution to determine malondialdehyde (MDA) concentration. Samples were
assayed in duplicate.
Data Analysis
Area under the curve (AUC) for insulin and glucose was calculated via the
trapezoidal method utilizing the data points from the FSIGT.158 Glucose effectiveness
(Sg), insulin sensitivity (Si), acute insulin response to glucose (AIRg) and disposition
index (DI) were calculated using minimal model software (MinMod Millennium, Version
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6.02) as previously reported.20 Any animal which did not fit the model with an R2 > 0.9
was removed prior to statistical analysis.
Results are expressed as mean + SE. Data were analyzed using the GLM
procedure of SAS (SAS Institute, Inc., Cary, NC, 2006) where horse was a random
variable, and fixed variables included treatment, and period along with all possible
interactions. The null hypothesis was rejected at α= . 5 f or main effects and
interactions, with trends defined when P < 0.10. Treatments were further separated using
Tukey’s test where appropriate. Contrasts were also conducted within Proc GLM to
examine differences between control (C) and treatment (T, both low and high).
Body weights were averaged to determine mean weight across each T period.
Daily hay and concentrate intake were evaluated in relationship to percent (%) BW.
Plasma TBARS concentrations were evaluated individually for d 0 and 14 samples.
Plasma TBARS data were also evaluated as normalized by subtracting the difference of d
14 and d 0 concentrations.
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CHAPTER III – RESULTS
Body Weight and Feed Intake
Results for mean BW were 541.81, 540.46, and 539.47 + 1.95 kg for C, L, and H
respectively. No effect of treatment (P = 0.72), period (P = 0.36), or treatment by time
interaction (P = 0.29) was found.
Feed intake results were calculated based upon mean values of daily hay and
concentrate intake, expressed as percent of BW consumed. Upon evaluation of hay
intake, trends were noted with regard to treatment (P = 0.097, Figure 3) and period (P =
0.094; Figure 4), but no interactions were observed (P = 0.180). Hay intake averaged
1.66, 1.71, and 1.69 + 0.01 % BW in kg for C, L, and H respectively (Figure 3). The
contrast between control and treatment groups showed a trend (P = 0.053), where
treatment resulted in an increased intake of 0.08% BW. Concentrate intake expressed as
percent of BW displayed no significant effects of treatment (P = 0.122, Figure 5), period
(P = 0.145) or interaction (P = 0.217). Contrast evaluation between control and treatment
groups revealed a trend (P = 0.053), with treatment resulting in increased concentrate
intake of 0.016% BW (Figure 5).
TBARS
Resveratrol treatment had no effect on plasma TBARS concentration after 14 d of
supplementation (P = 0.61; Figure 6). Period also did not have an effect on plasma
TBARS concentration (P = 0.83) and no interaction was noted (P = 0.99). Plasma
TBARS normalized for d 0 concentration also did not differ between treatments (P =
0.40) or periods (P = 0.93) and no interactions were observed (P = 0.86).
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Figure 3: Hay intake expressed as % of BW (kg) of mature Quarter Horse geldings (n =
6, mean + SE) in relation to resveratrol supplementation at low (L) or high (H) dosage, or
no supplementation (control C). Each period lasted 2 weeks. Trends are denoted with
brackets and symbols, where P < 0.10. Contrasts are defined as C versus treatment (L and
H resveratrol supplementation).
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Figure 4: Hay intake expressed as % of BW (kg) of mature Quarter Horse geldings (n =
6, mean + SE) in relation to period during resveratrol supplementation at low (L) or high
(H) dosage, or no supplementation (control C). Each period lasted 2 weeks. Trends are
denoted with brackets and symbols, where P < 0.10.
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Figure 5: Concentrate intake expressed as % of BW (kg) of mature Quarter Horse
geldings (n = 6, mean + SE) in relation to resveratrol treatment over 3 periods, lasting 2
weeks each. Trends are denoted with regard to contrasts, which are defined as C versus
treatment (L and H resveratrol supplementation), where P < 0.10.
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Figure 6: Plasma TBARS concentrations (mean + SE) for 6 mature Quarter Horse
geldings on d 14 of supplementation with low (L) or high (H) dose of resveratrol or
control (C, no supplementation). Plasma TBARS is expressed as malondialdehyde
(MDA) equivalents. No trends or significant differences are noted for treatment (P =
0.61), period (P = 0.83) or interactions (P = 0.99).
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FSIGT
There were no differences in baseline insulin concentrations between treatment
groups (P = 0.26), period (P = 0.99), or interactions (P = 0.36). Baseline plasma glucose
also did not differ in regards to treatment (P = 0.89), period (P = 0.56), or interaction (P =
0.34; Figure 7 and 8).
A representative glucose and insulin curve for C, L, and H treatment can be found
in Figures 9, 10, and 11, respectively. Curves were accepted for graphical representation
based upon their fit into the minimal model (R2 > 0.9).
There were no differences between treatment (P = 0.56), period (P = 0.41), and no
interaction (P = 0.20) were noted with regard to Sg. Similarly, Si was not affected by
treatment (P = 0.59), period (P = 0.14) or interaction (P = 0.79). Treatment, period, nor
interaction had an effect on AIRg, where P = 0.35, 0.98, and 0.43 respectively.
Disposition index (DI) was also not affected by treatment (P = 0.93) or period (P = 0.19)
and no interaction was displayed (P = 0.84). No differences between treatment (P =
0.84), period (P = 0.32), or interaction (P = 0.95) were noted with regard to AUC of
insulin. Likewise, AUC of glucose did not differ in regards to treatment (P = 0.80),
period (P = 0.82) or interaction (P = 0.97). A summary of the data can be found in Table
3.
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Figure 7: Baseline insulin concentration (mean ± SE) after an overnight fast in six
mature Quarter Horse geldings supplemented with resveratrol (low or high dose), or
control (no supplementation). No significant effects or trends of treatment (P = 0.26),
period (P = 0.99) or interactions (P = 0.36) were noted.
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Figure 8: Basal glucose concentration (mean ± SE) in six mature Quarter Horse geldings
sampled after an overnight fast and supplemented with resveratrol (low, L, or high, H,
dose), or control (C, no supplementation). No effects or trends of treatment (P = 0.89),
period (P = 0.56) or interactions ( P0.34) were noted. PVALUES
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Figure 9: Mean glucose and insulin concentrations (mean + SE) from a frequently
sampled intravenous glucose tolerance test (FSIGT) for the control (C, no
supplementation) horses (n=6) over 3 periods lasting 2 weeks each are displayed. Data
was collected and utilized for graphical representation when R2 > 0.9.
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Figure 10: Mean glucose and insulin concentrations (mean + SEM) from a
frequently sampled intravenous glucose tolerance test (FSIGT) for the low (L) dose
resveratrol supplemented horses (n=6) over 3 periods lasting 2 weeks each are displayed.
Data was collected and utilized for graphical representation when R2 > 0.9.
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Figure 11: Mean glucose and insulin concentrations (mean + SE) from a
frequently sampled intravenous glucose tolerance test (FSIGT) for the high (H) dose
resveratrol supplemented horses (n=6) over 3 periods lasting 2 weeks each are displayed.
Data was collected and utilized for graphical representation when R2 > 0.9.
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Figure 12: Basal glucose (Gb) concentrations (mean + SE) from a frequently
sampled intravenous glucose tolerance test (FSIGT) were calculated based on control (C,
no supplementation), low resveratrol supplementation (L) or high resveratrol
supplementation (H). Basal glucose is utilized conjunction with the minimal model
parameters. Significant interactions are noted with brackets and symbols.
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Table 3: Least squares means + SE for Minimal Model variables and area under
the curve (AUC) for glucose and insulin in regard to control (C, no supplementation), low
(L), or high (H) dose resveratrol supplementation in 6 mature Quarter Horse geldings in
response to a frequently sampled intravenous glucose tolerance test (FSIGT).
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CHAPTER IV – DISCUSSION

This work presents the results from a controlled study in which six moderately
exercised mature Quarter Horse geldings were supplemented with resveratrol to
determine if treatment affected glycemic response and oxidant status.
Resveratrol supplementation administered during this study was compounded
with polyethylene glycol. Although the C group (no supplementation) did not receive any
vehicle supplementation, energy substrates present in this compound add a negligible
amount to overall dietary components, and thus should not have had an effect on body
condition or energy status between C and T groups.
Body Weight and Feed Intake
Prior to the start of the study, horses were housed in an approximately 12 acre
pasture, and were utilized in West Virginia University’s Equestrian Technology course.
Horses were exercised lightly, mainly utilized for beginner to intermediate riding classes,
3 times per week. As an athletic horse, feed intake is important to ensure digestible
energy needs are met, especially for horses with little preference for forage. Contrast
between C and T demonstrate a potential use for resveratrol to increase feed intake in the
moderately exercised equine athlete. Increased levels of forage may provide a potential
benefit to the horse, as increased forage intake can lead to increased energy substrate
from hindgut fermentation and perhaps even an elevated hydration status.159 A period
effect was noted, with low hay consumption in the first period which may be attributable
to preference for pasture previously consumed over the hay being offered in the initial
days. Also, human error may have been a factor, as collection of daily refusals may have
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differed slightly from person to person. This could provide a potential benefit to the
athletic horse. While, the current aim of the study was not to evaluate effects effects of
resveratrol on body mass or composition, an increased intake attributable to
supplementation was noted. Within a moderate body condition, resveratrol has no effect
on body weight, but may have some use in increasing feed intake in the exercising horse,
although intake was minimal in comparison to overall daily intake.
TBARS
Resveratrol supplementation at low and high levels did not have an effect on
plasma TBARS (MDA concentration) in plasma. Other markers of oxidant status such as
glutathione, glutathione peroxidase, and nitric oxide were considered for this study,
however due to kit inconsistency with equine tissue and blood samples, they were not
used for this study. Still, speculation into the validity of the TBARS test must be
considered. Plasma TBARS is utilized to determine lipid peroxidation through the entire
body; however, the limitations with this assay must be noted. TBARS utilizes MDA, a
by-product of lipid peroxide to determine the amount of oxidation that occurred.
Oxidative stress has been shown to occur with specific modes of exercise, yet severity
and level of tissue damage have not always been consistent, even when similar exercise
and collection protocols are used.160 Large variation within this assay for equine models
has been noted numerous times, 117, 160, 161 with pre-exercise ranges measuring from 66 to
1048 nmol/L,161 and an apparent CV of >40% .160 Variations between studies including
diet, age, previous training history, and analytical methods may play a role in this
inconsistency. 162-164
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Elevated levels of plasma and serum TBARS have been observed after strenuous
exercise;165,166 yet, other research has shown long term exercise and acute physical
activity have not altered plasma TBARS concentration.167 Prolonged low-medium
intensity exercise has been the most frequently used exercise type to induce marked
oxidative stress in humans. 168, 169 In half marathon runners, an increase in plasma
TBARS of 600nmol/L after 40 minutes exercise at 40% VO2max was seen,178 but no
increase in TBARS was noted after a full marathon was completed.171 Horses that
completed a simulated race of 1000 + 200 m at an approximate speed of 16 m/s displayed
an increase in plasma TBARS (P < 0.01),161 and lipid peroxidation was higher in horses
finishing an 80 km endurance race when compared to those having finished only 21
km.117 While these results suggest that exercise should increase plasma TBARS
concentration as a reflection of increased lipid peroxidation, this study did not display a
similar result. During this study, horses were exercised at a moderate intensity during
each period. Although the exercise protocol was designed to be challenging to the horses,
the study design was not to determine effects of resveratrol on tolerance to an acute
exercise bout, but rather to determine if treatment would be beneficial to the conditioned
athletic horse. Marketing of resveratrol is currently aimed at the performance horse, with
claimed applications to those horses exercising at a moderate level, therefore; in order to
determine resveratrol effectiveness at this level of performance, exercise intensity was
held constant through the study. Perhaps if a more strenuous exercise test was included
with either an increased intensity, duration or both had been implemented, an increase in
plasma TBARS would have been observed.
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Literature mainly reports MDA concentration within plasma or serum,172 yet not
in skeletal muscle, which may provide a more accurate depiction of lipid peroxidation
occurring at the tissue level. Consideration must be given to the collection methods for
muscle tissue, as the biopsy procedure may increase damage to the sample. In
comparison to blood parameters, there are few studies utilizing muscle currently
available, with inconclusive results. In sedentary rats a slight increase in TBARS has
been shown in response to exhaustive exercise,164, 173 yet others have shown light to
moderate acute exercise bouts have not altered TBARS concentration at the tissue level,
without comparison to blood values.174 Further research is needed to validate testing
techniques, especially in an equine model and thus, TBARS was not evaluated in muscle
samples.
Sampling time after exercise may also affect reported TBARS concentrations.
Mixed information is available regarding the rates of production and clearance of TBARS
from the body, making sampling difficult. Human strength training studies commonly
sample 24 and 48h post exercise165, yet other studies have shown decreases after an acute
exercise bout as soon as 30 m post exercise, with returns to baseline ~1 h after
exercise.165 Equine studies report varying sampling times as well, with samples taken
during exercise117 as well as anywhere from 5 min161 to 16 h 160 and as far out as 2 wk
post exercise. 175 During this study, samples were collected ~24 h after an exercise bout
to be assayed for TBARS concentration. Intensity and duration of exercise may not have
been sufficient to elicit a detectable change in TBARS during this timeframe, or TBARS
may have returned to baseline by sample time. It is possible if samples had been collected
closer to the completion of exercise, or if an acute exercise bout had been conducted,
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differences may have been seen. Therefore, further work needs to be done to determine if
resveratrol has an effect on lipid peroxidation during or immediately following an acute
exercise bout.
Evaluation of other markers may have provided a more selective view of the
function of resveratrol within the horse, but for the purpose of this study, the TBARS
assay was to be used as an informative comprehensive parameter as to the effects of
resveratrol supplementation in an exercising athlete. Along with the limitations
mentioned above, assessment of the antioxidant enzyme pathways present in the body
were not measured, and therefore their contribution to preventing lipid peroxidation
cannot be determined. Resveratrol may impact these pathways as well, and further
information needs to be collected to elucidate its role for the equine athlete in various
types of exercise.
Glucose Tolerance and Insulin Sensitivity
Previously, resveratrol has been shown to enhance insulin stimulated glucose
transport, via up-regulation of GLUT 4, and improved glucose tolerance.8 Data from this
study shows resveratrol supplementation has no effect on glucose tolerance and insulin
sensitivity represented through Minimal Model analysis, nor baseline insulin and glucose
concentrations. Causes for this discrepancy may be due to the model utilized for the
study, along with body condition of the horses. Individual variability with regard to
treatment must also be considered, as each horse’s response to treatment may have been
different with regard to starting metabolic efficiency, and even sensitivity to the
compound.
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Both single bouts and prolonged repetitive aerobic exercise has been shown to
increase insulin sensitivity and glucose tolerance through sensitization of target tissues to
insulin, along with increased translocation of GLUT 4 via enhanced cellular
signalling.112-114 In the moderately exercised fit horse, optimum insulin signaling
pathways should already be in place, thereby making changes to an optimum system
difficult to produce. An increased presence of mitochondria within the cell due to
exercise-induced mitochondrial biogenesis make the muscle cell more energetically
efficient, while allowing for increased cellular oxidative respiration.176 Having these
systems already in place and being conditioned to exercise leaves little room for
resveratrol to impact these pathways. Perhaps, if an obese or unfit model was utilized,
placed into a similar study and evaluated for increased insulin sensitivity and glucose
tolerance, different results may have been displayed. Obesity is seen as an increase in
body condition score, which has been proven to decrease insulin sensitivity, thereby
impacting glucose metabolism.8 Obese horses were found to have a lower Si and relied
primarily on Sg for glucose disposal, rather than insulin signaling pathways.20 This
disease state rather than an athletic model may be a potential niche for resveratrol
supplementation from a glucose tolerance standpoint, due to its potential ability to
increase insulin sensitivity and increase effectiveness of this mechanism.150 Resveratrol
may impact various parameters of the Minimal Model, including Si, AIRg and DI for its
properties relating to increasing tissue sensitivity to insulin, enhancement of pancreatic cell function, and the body’s ability to mediate its own insulin response.
At the same time, resveratrol is known to up-regulate SIRT1 gene expression and
down regulate PPAR, together which influence the utilization of fat as an energy
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substrate, along with inhibition of inflammatory status, both of which may help to
modulate the confounding aspects of insulin resistance seen with obesity.123, 152, 157
Increasing oxidation of lipids as a fuel source may also be beneficial to the endurance
athlete, which may be a potential model for further investigation, while reduction in
inflammation may prove useful in athletic horses experiencing osteoarthritis and other
orthopedic injuries.

72

CONCLUSIONS
Resveratrol supplementation in moderately exercised horses resulted in few
apparent effects. Trends toward increased feed intake expressed as a percent of BW from
resveratrol supplementation may be cause for further investigation for the performance
animal; however, it is important to consider the small amount of feed intake seen in
regard to resveratrol supplementation when compared to the total amount of intake per
day. Resveratrol supplementation has no effect on glycemic and insulinemic responses as
tested by a FSIGT, along with baseline insulin and glucose concentrations, in this
exercising equine model. Plasma TBARS was also unaffected by supplementation;
however, a more in depth evaluation of the actions of resveratrol in the exercising model
is needed to discern its functions among antioxidant enzyme activity. From this study,
the marketing of resveratrol as a supplement to increase glucose tolerance and reduce
ROS damage in performance horses is not supported. Evaluation of resveratrol within a
different athletic model, such as endurance exercise or ability to tolerate acute exhaustive
bouts of exercise, with regard to fat metabolism, oxidant status, and inflammation may
uncover other beneficial functions of resveratrol not assessed here. Therefore, further
research is needed to more thoroughly examine the possible effects of resveratrol
supplementation in the horse.
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